Document is current
Any future updates will be listed below
-
Authors
Capinha, Francisco https://orcid.org/0000-0001-9403-1796
Carvalhana, Sofia https://orcid.org/0000-0001-6120-2333
Cortez-Pinto, Helena https://orcid.org/0000-0002-8537-8744
-
Funding
Funding for this research was provided by:
Universidade de Lisboa
- License Information
-
More Information
Article History
Received: 23 July 2024
Accepted: 3 February 2025
First Online: 1 March 2025
Declarations
:
: HCP–Lectures and advisory board fees from Orphalan, Novo Nordisk, EISAI and Advanz Pharm.
